Skincare Brand AP Chem Debuts Age-Decelerating Products and Stigma-Breaking Social Campaign

AP Chem has launched its newest age-decelerating skincare aimed at the Xennial and Gen X community that is both results-driven and accessibly priced. 

 

As a science-forward skincare brand, AP Chem combines classic ingredients with clinically-proven Alt-Pharma ingredients to create a power-packed regimen. The brand’s approach to combining classic and unique skincare ingredients is inspired by the founder’s diagnosis with an autoimmune and inflammatory disease, which led her on a journey to explore both classic and alternative treatments, including psychedelic treatment.

Based on both founders’ belief that inflammation is a core component of most skin and overall health conditions, the brand addresses this universal concern with anti-inflammatory ingredients for optimal skin renewal. To complement the debut product, microDOSE Magical Moisturizer, AP Chem’s DERMAverse is expanding to welcome DOPEamine Uplifting & Smoothing Serum and EYEahuasca Enlightening Eye Treatment to the collection.

 

The brand’s proprietary KETAmino Acid Complex takes centerstage along with hero neuropeptide Gamma Aminobutyric Acid (GABA) and hero anti-inflammatory Baicalin in the thoughtfully-curated, lab-tested formulas. DOPEamine Uplifting & Smoothing Serum ($125) improves the appearance of fine lines and wrinkles, skin texture and tone, as well as skin elasticity, so facial contours appear more defined. Similarly, EYEahuasca Enlightening Eye Treatment ($85) helps reduce the appearance of lines and wrinkles, and visibly lifts and firms while brightening the appearance of dark circles. The balm-like texture is lightweight yet nourishing, leaving eyes feeling refreshed, de-stressed and awakened — instantly and over time.

Founded by beauty industry veteran, Sandra Statz, and leading dermatologist Dr. Sherwin Parikh, AP Chem’s mission is rooted in Sandra’s challenging health journey. Her diagnosis with an autoimmune and inflammatory disease led her to explore alternative treatment methods – most notably the power of psychedelic treatment. Statz’s experience drives AP Chem’s advocacy for psychedelic treatment while creating a platform to destigmatize mental and physical conditions. To put this ethos into action, AP Chem partners with The Ketamine Fund, a nonprofit organization that provides free Ketamine treatment and mental health support to veterans suffering from PTSD.